Saleh Shamse Basha/LinkedIn
Jun 26, 2026, 07:10
Saleh Shamse Basha: Why APTT Alone Can Be Misleading During UFH Monitoring
Saleh Shamse Basha, Senior Hematology Technologist (Reference Lab, HQ) at PureLab, shared a post on LinkedIn:
“A patient post surgical inflammation on unfractionated heparin (UFH).
APTT: 66 sec.
In thise case can you relay on APTT alone to monitor the UFH??
The answer is : No.
But, Why?
During the acute-phase response, Factor VIII is often elevated.
Increased FVIII shortens the APTT, meaning that an APTT of 66 seconds may underestimate the true anticoagulant effect of UFH.
That’s the trap.
That’s why we should use Anti-Xa assay while monitoring patient on UFH.”
Stay updated with Hemostasis Today.
-
Sep 24, 2026, 12:56Maria Helena Parrinello: A New Score for Chronic GvHD Risk Assessment at the SIE Congress
-
Sep 24, 2026, 12:44Shehab Mohamed: TP53 Mutations and Outcomes in Myeloproliferative Neoplasms
-
Sep 24, 2026, 12:34Francesca Palandri: Is There Still a Place for Splenectomy in ITP in the Modern Era?
-
Sep 24, 2026, 12:15Cedric Hermans: RPTH Illustrated Review on Von Willebrand Disease
-
Sep 24, 2026, 11:48Factor XII Inhibition and the Future of Contact Pathway Targeting
-
Sep 24, 2026, 08:55Andres Gudino: Clot Characterization Through Hounsfield Units in Ischemic Stroke
-
Sep 24, 2026, 06:52Gina Sado: Screening-Detected Atrial Fibrillation Carries High Risk of Heart Failure
-
Sep 24, 2026, 06:33Benjamin Vipler: Optimal Oral Anticoagulation Choice in Atrial Fibrillation and Advanced CKD
-
Sep 24, 2026, 06:08Christopher Salerno: AI-Powered At-Home Anemia Screening Advances Telehealth Access